Lot certificates published
Plain, secure packaging

Compound monograph

GHK (Prezatide)

GHK is the uncomplexed tripeptide ligand of the GHK-copper complex, identified in 1977 as a growth-modulating tripeptide from human plasma.

Published: 2026-09-13Last updated: 2026-10-15Literature/identifier verification: 2026-09-13
Also known asGHKGlycyl-L-histidyl-L-lysineTripeptide-1NSC-379527

01

Identity & nomenclature

GHK is the uncomplexed tripeptide ligand of the GHK-copper complex, identified in 1977 as a growth-modulating tripeptide from human plasma.

GHK, GHK-Cu and Pal-GHK are three different substances: an uncomplexed peptide, a copper coordination species, and a covalently lipidated derivative. CAS 49557-75-7 belongs to THIS entry, the free tripeptide. The copper complex is 89030-95-5. That distinction has practical consequences — certificates of analysis in this market have carried the free-tripeptide number on copper-complex product, which describes the wrong substance.

Canonical name: Prezatide.

Declared aliases and development codes: GHK, Glycyl-L-histidyl-L-lysine, Tripeptide-1, NSC-379527.

02

Molecular properties

Molecular formulaC14H24N6O4
Molecular mass340.38 Da
CAS Registry Number49557-75-7
PubChem CID73587
UNII39TG2H631E
One-letter sequenceGHK
Three-letter sequenceGly–His–Lys
Terminal groupsFree N-terminus; Free C-terminal carboxyl

Three residues with a free N-terminal amine and a free C-terminal carboxyl. No modifications. Copper is NOT part of this entry — see nomenclatureNotes.

03

Structural characteristics

Its matrix provenance is sourced: proteolysis of SPARC, a matrix-associated protein, yields KGHK, GHK and longer peptides. That provenance is the basis for its secondary matrikine classification. Two cautions belong with it. Most of the angiogenic activity in that work mapped to KGHK rather than to the GHK tripeptide, and was reported as sequence-specific and apparently independent of bound copper — so neither the longer-fragment results nor a copper dependence should be transferred to GHK. Separately, spectroscopic work on Cu(II) coordination reports three nitrogen atoms and one oxygen in a square-planar arrangement, with the major and minor species present varying by pH. Copper binding is therefore established; a single invariant coordination structure is not.

Terminal features: Free N-terminus, Free C-terminal carboxyl.

04

Molecular targets & mechanisms

05

Analytical considerations

For material specified as uncomplexed GHK, quantitative metal analysis is an identity-relevant measurement rather than a cosmetic one — the peptide ion alone does not establish the absence of copper, and acidic chromatography can change the coordination state before detection. Any experiment described as copper-independent must also account for metals already present in the medium. Neither solution colour nor amino-acid composition establishes the complete identity.

Disagreements and mix-ups

Points where sources disagree about this compound's identity, or where a name or form is easily confused with another, as noted in this record. The discrepancy register quotes the passage for each one.

What the studies reported

Each finding describes one cited study in its stated model. These observations are specific to that study and do not establish effects in other settings.

Cell and tissue studies

  • SPARC in trypsin-digestion and tandem-mass-spectrometry assays

    Lane et al. identified GHK after tryptic cleavage of SPARC by comparing the released peptide with a GHK standard in tandem mass spectrometry.

    Reference [2]
  • Bovine aortic endothelial cells in a cord-formation assay

    Lane et al. observed little effect of GHK on endothelial cord number in bovine aortic endothelial cultures.

    Reference [2]

06

Verified bibliography

Cited studies by type

The 3 papers this record cites, counted by the kind of work each reports. A count is the size of this record's selection, not of the research that exists, and says nothing about results, safety, effectiveness or approval.

A paper can report more than one kind of work. Each count opens those papers in the bibliography. Compare every record on the Evidence Map.

  1. Reference 1

    Growth-modulating serum tripeptide is glycyl-histidyl-lysine.

    Schlesinger DH, Pickart L, Thaler MM

    Experientia · 1977-03-15 · Journal Article

    current
  2. Reference 2

    SPARC is a source of copper-binding peptides that stimulate angiogenesis.

    Lane TF, Iruela-Arispe ML, Johnson RS, Sage EH

    The Journal of cell biology · 1994-05 · Journal Article

    current
  3. Reference 3

Study models of these references

What kind of experiment each cited paper reports, taken from its abstract unless marked. Not a summary of results.

ReferenceStudy models
Schlesinger DH et al. 1977No abstract available; study type not determined
Lane TF et al. 1994Study models reported: in vitro; in vivo (subject not stated) · from the abstract
Laussac JP et al. 1983Chemical, structural or analytical study; no biological model reported

Compare

Record history

Published 2026-09-13.

  • : Sequence and structure
  • : Sequence and structure

Each entry names the parts of this record that changed on that date. Changes to links between records and to catalogue links are not listed. This history covers the tracked record fields; study findings are not listed here.

Cite this record: Purely Peptides Research Library. GHK (Prezatide). Published 2026-09-13; updated 2026-10-15. https://purelypeptides.org/research/compounds/ghk/

10

Methodology & citation verification

Reference identity is checked against official PubMed metadata. Local deterministic receipts bind each normalized title and canonical metadata record to its verification date. Scientific values remain absent when an authoritative source has not been verified.

Read the full methodology →